GlassScriptPhysician profile
Toby Heller
NPI 1518592567
$8,156.60
in general payments reported to CMS, 2019-2025
24 companies · $25.88 in 2025
The $25.88 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,122 · 2022: $5,723 · 2023: $1,261 · 2024: $24.10 · 2025: $25.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,311.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,898.32 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,357.83 | 2021-2023 | Xifaxan, Trulance |
| Celgene Corporation | $1,222.92 | 2021-2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $729.87 | 2021-2023 | Entyvio, Gattex |
| Pfizer INC. | $545.98 | 2021-2023 | |
| Janssen Biotech, INC. | $434.75 | 2022-2023 | Stelara |
| Qol Medical, LLC | $275.35 | 2021-2023 | Sucraid |
| Merck Sharp & Dohme LLC | $270.84 | 2021-2023 | Dificid |
| E.R. Squibb & Sons, L.L.C. | $240.62 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $198.63 | 2021-2023 | Clenpiq |
| Amgen INC. | $191.44 | 2022-2023 | Avsola, Amjevita |
| Daiichi Sankyo INC. | $180.48 | 2022 | |
| Janssen Scientific Affairs, LLC | $145.71 | 2022 | |
| Redhill Biopharma INC. | $118.71 | 2021-2023 | Talicia, Movantik, Aemcolo |
| Regeneron Healthcare Solutions, INC. | $64.66 | 2022-2023 | Dupixent |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $52.32 | 2021-2022 | |
| Medtronic, INC. | $49.98 | 2024-2025 | Interstim, Signia |
| Ironwood Pharmaceuticals, INC | $39.76 | 2021 | |
| Exact Sciences Corporation | $39.26 | 2023 | Cologuard Collection Kit |
| Braintree Laboratories, INC. | $23.35 | 2023 | Sutab |
| Lilly USA, LLC | $21.25 | 2023 | |
| Ardelyx, INC. | $20.73 | 2023 | Ibsrela |
| Fresenius Kabi USA, LLC | $19.25 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $14.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Toby Heller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.